Moreover, four studies investigated the relationship between RASSF1A hypermethylation in peripheral blood and the risk of HCC, and the diagnosis of HCC was confirmed by imaging techniques and serum AFP levels, rather than through pathological examination [56–59]. Here, RASSF1 is linked to hepatocellular carcinoma.